Alembic Pharmaceuticals has received an Establishment Inspection Report (EIR) for the inspection carried out by US Food and Drug Administration (USFDA) at the company's API - I & API - II facility located at Panelav. The inspection was conducted from May 26, 2025 to May 31, 2025.
Alembic Pharmaceuticals, a vertically integrated research and development pharmaceutical company, has been at the forefront of Healthcare since 1907.